Moreover, as EZH2 and DNMTs cooperate in transcriptional regulation, it might be interesting to explore the effects of associating EZH2 inhibitors with DNA demethylating agents in B-cell lymphoma cells. The gene discussed is EZH2; the disease is B-cell non-Hodgkin lymphoma.